Skip to main content
. 2015 Dec 1;1:30. doi: 10.1186/s40780-015-0032-5

Table 2.

Renal function and prescribed doses

CLCr (mL/min) N Median of initial dose (mg/day, range) Defined initial dose (mg/day) Developed adverse effects Developed adverse effects with over defined initial dose
>60 127 150 (25–450) 150 41 (32.3 %) 1 (2.4 %)
>30–≤60 55 75 (25–150) 75 17 (30.9 %) 8 (47.1 %)
≤30 13 50 (25–150) 25 or 50 5 (38.5 %) 2 (40.0 %)